AbbVie (ABBV) Options Chain & Prices $264.45 -0.67 (-0.25%) Closing price 09/25/2026 03:59 PM EasternExtended Trading$264.60 +0.15 (+0.06%) As of 09/25/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Options Chain Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest ABBV Put and Call Options List 1/19/2029 1/21/2028 9/17/2027 6/17/2027 5/21/2027 3/19/2027 2/19/2027 1/15/2027 12/18/2026 11/20/2026 11/6/2026 10/30/2026 10/23/2026 10/16/2026 10/9/2026 10/2/2026 Options Date Put and Call Options Put Options Call Options Options Type All In The Money Out of The Money Moneyness With Volume Without Volume All Volume Strike Price Min Strike Price Max Export ExpiresStrike PriceClose PricePut/CallVolumeVolume AskVolume BidOpen InterestImplied VolatilityDeltaTrades10/2/2026$220.00$44.754Call1 - - 1(+0)48.34% (-0.64%)0.997327110/2/2026$235.00$0.043Put17134354(-1)37.01% (-0.88%)-0.009613610/2/2026$240.00$0.075Put944110(+9)33.72% (-0.93%)-0.017242410/2/2026$242.50$0.101Put100 - - 0(+0)32.08% (-0.99%)-0.023434610/2/2026$245.00$0.138Put8013130(+0)30.45% (-1.07%)-0.0322421010/2/2026$245.00$19.900Call1 - - 11(+1)30.45% (-1.07%)0.967855110/2/2026$247.50$0.195Put1171123(+0)28.90% (-1.13%)-0.0452661610/2/2026$250.00$0.287Put108516107(+0)27.57% (-1.14%)-0.0654851810/2/2026$252.50$0.447Put6 - 144(+15)26.59% (-1.01%)-0.097669510/2/2026$252.50$12.712Call1 - - 2(+0)26.59% (-1.01%)0.9029261 Get the Latest News and Ratings for ABBV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AbbVie and its competitors with MarketBeat's FREE daily newsletter. 10/2/2026$255.00$0.723Put593014219(+10)26.03% (-0.77%)-0.1469522610/2/2026$255.00$10.489Call4 - - 37(+0)26.03% (-0.77%)0.854084310/2/2026$257.50$1.163Put511334105(+75)25.71% (-0.53%)-0.215162610/2/2026$257.50$8.427Call14 - - 1(+0)25.71% (-0.53%)0.786543910/2/2026$260.00$1.795Put3633058(-10)25.42% (-0.41%)-0.300311510/2/2026$260.00$6.557Call25 - 392(+1)25.42% (-0.41%)0.7022561110/2/2026$262.50$2.646Put66 - 58136(-5)25.04% (-0.47%)-0.3993262710/2/2026$262.50$4.902Call76316107(-6)25.04% (-0.47%)0.6043932710/2/2026$265.00$3.743Put37 - 1958(+5)24.57% (-0.69%)-0.5079061410/2/2026$265.00$3.489Call3105147282(+6)24.57% (-0.69%)0.4971766210/2/2026$267.50$5.110Put3 - 1163(+145)24.04% (-1.04%)-0.619843210/2/2026$267.50$2.343Call69153277(+73)24.04% (-1.04%)0.3867993510/2/2026$270.00$6.760Put4 - 47(+0)23.53% (-1.48%)-0.726678110/2/2026$270.00$1.474Call2691839480(-63)23.53% (-1.48%)0.2816796010/2/2026$272.50$0.872Call1132174103(+29)23.15% (-1.89%)0.1912615110/2/2026$275.00$0.500Call761325465(+6)23.08% (-2.13%)0.1230832210/2/2026$277.50$0.298Call137141366(+12)23.55% (-2.01%)0.0789412010/2/2026$280.00$0.199Call3111757(+1)24.68% (-1.44%)0.0540541110/2/2026$282.50$0.153Call1 - 145(+0)26.40% (-0.58%)0.040728110/2/2026$285.00$0.128Call156198(+0)28.44% (+0.32%)0.0328585End-of-day options data provided by Trade Alert and Intrinio. Related Companies and Tools Related Companies Amgen Options Gilead Sciences Options Moderna Options Abbott Laboratories Options Bristol Myers Squibb Options Johnson & Johnson Options Eli Lilly and Company Options Merck & Co., Inc. Options Pfizer Options Vertex Pharmaceuticals Options Options Chain Tools Short Interest TrackerShort Interest IncreasesShort Interest DecreasesUnusual Call VolumeUnusual Put Volume This page (NYSE:ABBV) was last updated on 9/25/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredAnalyst nicknamed “The Prophet” issues new warning for AmericaWhitney Tilson exposed a major company on 60 Minutes in an Emmy-winning investigation - the stock lost nearly ...Stansberry Research | SponsoredMake this "Money Move" Before Midterms November 3rdAddison Wiggin has interviewed Warren Buffett, questioned two former Treasury Secretaries, and warned of the 2...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbbVie With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
